Christopher J. Logothetis, MD of MD Anderson Cancer Center compares the three trials, CHAARTED, STAMPEDE, and LATITUDE, and discusses how clinicians choose between chemotherapies for patients with prostate cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
CHAARTED & STAMPEDE versus LATITUDE
